Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.7690
+0.0144 (1.91%)
At close: May 12, 2025, 4:00 PM
0.7818
+0.0128 (1.66%)
After-hours: May 12, 2025, 7:59 PM EDT

Palisade Bio Market Cap

Palisade Bio has a market cap or net worth of $3.38 million as of May 12, 2025. Its market cap has decreased by -37.39% in one year.

Market Cap
3.38M
Enterprise Value
-6.28M
1-Year Change
-37.39%
Ranking
Category
Stock Price
$0.77

Market Cap Chart

Since March 30, 2007, Palisade Bio's market cap has decreased from $82.40M to $3.38M, a decrease of -95.90%. That is a compound annual growth rate of -16.16%.

History

DateMarket Cap% Change
May 9, 20253.30M50.00%
Dec 31, 20242.20M-59.26%
Dec 29, 20235.40M-32.50%
Dec 30, 20228.00M-54.55%
Dec 31, 202117.60M15.79%
Dec 31, 202015.20M300.00%
Dec 31, 20193.80M-33.33%
Dec 31, 20185.70M-78.08%
Dec 29, 201726.00M-16.13%
Dec 30, 201631.00M-67.02%
Dec 31, 201594.00M-60.62%
Dec 31, 2014238.70M6.23%
Dec 31, 2013224.70M203.65%
Dec 31, 201274.00M55.14%
Dec 30, 201147.70M-51.92%
Dec 31, 201099.20M57.96%
Dec 31, 200962.80M20.54%
Dec 31, 200852.10M-54.10%
Dec 31, 2007113.50M37.74%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 678.30B
Johnson & Johnson 370.87B
UnitedHealth Group 343.58B
AbbVie 335.74B
Novo Nordisk 292.03B
Abbott Laboratories 229.64B
Novartis AG 213.30B
AstraZeneca 210.42B
Market Cap Rankings